ECM Therapeutics has licensed patents from the University covering a platform of technologies from the McGowan Institute of Regenerative Medicine Lab of Stephen Badylak.
Pitt Spinout Globin Solutions Raises $5 Million to Commercialize Carbon Monoxide Poisoning Antidote
A Pitt professor is working to commercialize a discovery made in the lab of Mark Gladwin, Chairman of the Department of Medicine.
Pitt Spinout LyGenesis Raises $3 Million to Pursue Clinical Study
LyGenesis is commercializing technology developed by Eric Lagasse of the McGowan Institute for Regenerative Medicine to grow functional liver tissue inside lymph nodes.